enVVeno Medical (NVNO) Free Cash Flow (2017 - 2026)

enVVeno Medical's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$3.2 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 19.41% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$14.8 million (up 14.68% YoY), while the FY2025 annual figure was -$15.6 million, up 7.72% from the prior year.
• Free Cash Flow was -$3.2 million for Q1 2026 at enVVeno Medical, up from -$3.4 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$3.2 million in Q1 2026 to a low of -$5.1 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$4.1 million across 5 years, with a median of -$4.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 88.55% in 2022, then soared 32.61% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$3.9 million in 2022, then declined by 28.77% to -$5.0 million in 2023, then slipped by 2.65% to -$5.1 million in 2024, then soared by 32.61% to -$3.4 million in 2025, then climbed by 5.95% to -$3.2 million in 2026.
• The last three Free Cash Flow figures came in at -$3.2 million (Q1 2026), -$3.4 million (Q4 2025), and -$4.4 million (Q3 2025), per Business Quant data.